KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$13.04 USD
+0.54 (4.32%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $13.05 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/05/2024
Time: -- |
7/2024 | $-0.65 | 0.00% |
Earnings Summary
For their last quarter, KalVista Pharmaceuticals (KALV) reported earnings of -$1.02 per share, missing the Zacks Consensus Estimate of -$0.71 per share. This reflects a negative earnings surprise of 43.66%. Look out for KALV's next earnings release expected on September 05, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 12.16%.
Earnings History
Price & Consensus
Zacks News for KALV
Are Medical Stocks Lagging Cabaletta Bio (CABA) This Year?
KALV: What are Zacks experts saying now?
Zacks Private Portfolio Services